Fingerprint
Dive into the research topics of 'Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically